Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCA12 is a member of the ATP-binding cassette (ABC) transporter superfamily and functions as a transmembrane lipid transporter. It is predominantly expressed in epidermal keratinocytes, where it moves lipids, such as glucosylceramides, from lamellar granules (LGs) to the outer layers of the skin, enabling formation of the lipid lamellae crucial for skin barrier function. Mutations in the ABCA12 gene result in severe forms of congenital ichthyoses due to defective lipid transport and skin barrier formation. ABCA12 also plays roles in keratinocyte differentiation, cholesterol efflux, and possibly insulin secretion.
Drugs (if developed) would likely act by modulating lipid transport or keratinocyte function; mechanistic modulation may involve correction or enhancement of lipid delivery to epidermis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP binding cassette subfamily A member 12 (ABCA12).